2018 recipient of the Lung Foundation Australia/Lizotte Family Research Award for Idiopathic Pulmonary Fibrosis (IPF) Research.
Together with A/Prof. Glen Westall, Dr Jaffar's main role is establishing the Alfred Lung Fibrosis (ALF) Biobank of lung samples from patients undergoing transplantation for pulmonary fibrosis. Jade processes, stores and isolates cells from the lung tissue as well as maintains records for each patient (lung function, medication history, consent).
Dr Jaffar's career and research interests include: Interstitial lung disease, Asthma, COPD; the extracellular matrix; pulmonary fibrosis; respiratory medicine; therapy/biomarker development.
Dr Leona Dowman -
Leona Dowman is a senior exercise physiologist in the pulmonary rehabilitation program at Austin Health in Melbourne. She recently completed her PhD in ‘Therapeutic interventions in interstitial lung disease. Exercise training and supplemental oxygen’ through the La Trobe University, Melbourne. For her PhD she led a multi‐site randomised controlled trial which defined the benefits of pulmonary rehabilitation for ILD across disease subgroups, published in 2017 in Thorax.
Leona Dowman is currently holds a postdoctoral position La Trobe University, under Prof Anne Holland. Her main role will be to develop and conduct the first randomised controlled trial, across 4 Australian centres, comparing the clinical benefits of a high intensity interval training protocol to the standard continuous exercise training method used in pulmonary rehabilitation in people with fibrotic interstitial lung disease.
Dr Yet Khor is a graduate of the University of Tasmania. She completed her basic physician training at the Royal Melbourne Hospital. She trained as a Respiratory and Sleep Physician at the Austin Hospital and Western Health in Melbourne. She attained her Fellowship to the Royal Australasian College of Physicians in 2014. Currently, she works at the Austin and Alfred Health. She has been actively involved in developing the Interstitial Lung Disease Service at Austin Health.
She also actively engages in research activities. She is currently pursuing her PhD on the role of supplementary oxygen therapy in interstitial lung disease at the University of Melbourne. Her main research interests are the epidemiology and management of interstitial lung disease.
Recipient of the Lung Foundation Australia's David Wilson PhD Scholarship.
After completing her FRACP in Respiratory and Sleep Medicine in 2015, Dr Adelle Jee commenced her career in clinical research with a PhD at the University of Sydney and Royal Prince Alfred Hospital. Dr Jee’s project aims to validate the proposed Idiopathic Pneumonia with Autoimmune Features (IPAF) criteria as identified and defined by a European Respiratory Society/American Thoracic Society taskforce, and better characterise this fascinating but poorly understood group of patients.
Dr Jee’s motivation to pursue clinical research was shaped by her real-life experience and many unanswered questions faced when managing patients with ILD. Although her main research focus is on interstitial lung disease, particularly of an idiopathic and autoimmune aetiology, she also has interests in the clinical management of patients with general respiratory and sleep disorders. Dr Jee is the successful recipient of the Lung Foundation Australia David Wilson PhD scholarship in idiopathic pulmonary fibrosis and looks forward to the ongoing opportunity to collaborate with physicians and scientists across multiple disciplines and integrate her research findings with clinical practice.
Kaj received his Bachelor of Applied Science in Biology and Medical laboratory research from Saxion University of Applied Science, Netherlands in 2013, during which he developed a strong interest in regenerative medicine. In 2013 he enrolled in the new jointly developed Master Programme “Regenerative Medicine & Technology” at the University of Utrecht and Technical University Eindhoven, Netherlands. The focus of his Master degree was on reinforcing biomaterials to regenerate articular cartilage and the prevention of epigenetic silencing of γ-retroviral vectors in stem cells.
In December 2016 Kaj started his Dual Degree PhD in the laboratory of Professor Darryl Knight at the University of Newcastle where his focus is on epithelial-fibroblast cross-talk in Idiopathic Pulmonary Fibrosis (IPF) to gain a deeper understanding of IPF pathology. After 2 years, in December 2018 Kaj will commence the final two years of his PhD in the laboratory of Dr. Janette Burgess at the University Medical Centre Groningen where he is rewarded with an Abel Tasman Talent Program Scholarship.
Dr Alan Teoh is currently a 3rd year respiratory and sleep advanced trainee working at Westmead Hospital.
Dr Teoh completed his Bachelor of Medicine and Surgery at the University of Tasmania. He completed his BPT training at RPA hospital and continued his respiratory advanced training at Westmead Hospital. He has a special interest in interstitial lung diseases, particularly idiopathic pulmonary fibrosis which will be the focus of his PhD research in 2018.
Dr Jyotika Prasad is a Respiratory and Sleep physician at the Alfred and Royal Melbourne hospital and is undertaking doctoral studies through Monash University. Dr Prasad's research interests include physiology of disease progression in IPF and LAM as well as understanding and improving diagnostic processes for patients with interstitial lung disease.
Ingrid is currently a PhD student at the Menzies Institute for Medical Research, University of Tasmania researching idiopathic pulmonary fibrosis in Australia. After completing her medical degree in Cuba, she worked as a physician at the national public hospital in St. Lucia for seven years after which she worked with the local Ministry of Health in public health and policy in the field of HIV. Ingrid has since then worked with regional governmental agencies in the Caribbean (Caribbean Public Health Agency and CARICOM Secretariat) in the area of public health policy and planning, taking a break in 2014 to complete a Master’s Degree in Health Economics and Policy at the University of Adelaide. Ingrid’s research during her PhD will focus on the epidemiological profile of IPF in Australia, quality of life of persons living with IPF and the economic burden with the aim of developing a disease simulation model to predict patient outcomes and evaluate the cost-effectiveness of interventions for IPF
Dr Matthew Parker - Clinician scientist
Dr Matthew Parker is a rheumatologist with a special interest in connective tissue and autoimmune diseases. He completed his FRACP in 2017 with a fellowship in Manchester, UK, funded by the Leanne Stafford Award, researching idiopathic inflammatory myopathies. He works at Royal Prince Alfred Hospital and is a Clinical Lecturer at The University of Sydney.
He considers that an early accurate diagnosis of CTD-ILD is of paramount importance in delivering appropriate management and is planning to complete a PhD studying the pulmonary manifestations of connective-tissue diseases.
Dr Britt Clynick - Postdoctoral Fellow
Dr Clynick completed a Bachelor of Science with first class Honours in Pathology and Laboratory Medicine at the University of Western Australia, where she continued on in the department to complete her PhD in 2018 in the field of Cancer Genomics. Currently, she works for the Institute of Respiratory Health at the Harry Perkins Research Institute in Perth, with a main research focus on interstitial lung disease, particularly in the molecular processes underlying idiopathic lung fibrosis.
Dr Hayley Barnes - Clinician & PhD Student
Hayley Barnes completed her FRACP training in 2018 and is now working as a Respiratory and Sleep Physician. She is currently undertaking her PhD in Improving Clinical and Biological Approaches to Improving Diagnostic Confidence of Chronic Hypersensitivity Pneumonitis through the Alfred Hospital and the University of California, San Francisco. She has also completed degrees in Biomedical Science, Masters of Public Health, and has been working for the Cochrane Collaboration for over 10 years.
She is passionate about good quality research for ILD, is an Editor of the Cochrane Pain and Palliative Care Review Group, and a tutor in statistics and epidemiology at Monash University. She is supported by an NHMRC scholarship and has previously received the LFA/Cochrane Airways Scholarship.
Tylah Miles - PhD Student
Tylah was awarded 1st class Honours in pharmacology in 2017 for her research project investigating the role of B cells in the mouse model of bleomycin-induced lung fibrosis. In early 2018 she commenced a PhD at the University of Western Australia to continue her research with A/Prof Cecilia Prele. She is focusing on the role of the immune system in the pathogenesis of Idiopathic Pulmonary Fibrosis.
Archana Gaikwad - PhD Student
Archana Gaikwad is a PhD student at University of Tasmania, Launceston campus. Her doctoral research investigates role of endothelial to mesenchymal transition (EndoMT) in pulmonary hypertension and interstitial fibrosis in IPF. She had been awarded with Lung Foundation Australia/ David Wilson CREATE PhD scholarship in IPF research 2019. Before starting her doctorate, she comes with experience of over 10 years in global companies including GlaxoSmithKline, Novartis and Becton, Dickinson (BD) Medical. During her tenure, she was involved in the development of new affordable, point of care diagnostics for Tuberculosis and Immunoassays for Malaria, Dengue and Typhoid. She has worked with global organisation such as World Health Organization (WHO), FIND- TB organisation, Program for Appropriate Technology in Health (PATH) and regulatory agencies across the world. She also has expertise in managing each aspects of the clinical trials ( Phase I- IV) for newly developed therapeutic treatments and diagnostics. She holds a postgraduate certificate in clinical trial management from National University of Singapore and a master’s degree in microbiology from India.
Dr Gabriella Tikellis - Postdoctoral Fellow
Dr Gabriella Tikellis (PhD) is a researcher with a background in epidemiology and biostatistics across various disciplines. Dr. Tikellis has also worked in the area of ophthalmology, diabetes and cardiovascular disease through her research at the Centre for Eye Research Australia. In the past 10 years, a main focus of her research has been the epidemiology of cancers in particular, pediatric cancer at the Murdoch Childrens Research Institute in Melbourne as part of the International Childhood Cancer Cohort Consortium (I4C) and prostate cancer as Coordinator of the Australia and New Zealand Prostrate Cancer Outcomes registry. She has also spent some time working at Cochrane Australia analysing the findings from a NHMRC funded translational project. She is now pursuing her interest in translational research as part of the Translation and Education Support (TEDS) component of the CRE in Pulmonary Fibrosis.
Mariana Hoffman Barbosa - Postdoctoral Fellow
Mariana is doctor in rehabilitation science from Universidade Federal de Minas Gerais and KULeuven. During the PhD she worked with inspiratory muscle training for patients with advanced lung diseases and on the waiting list for lung transplantation. She completed her master in Adapted Physical Activity fin KULeuven, Belgium and her post-graduation in Cardiorespiratory Rehabilitation in the Einstein Hospital in São Paulo. She is a respiratory physiotherapist and has been working providing pulmonary rehabilitation, in private practice, to patients with lung fibrosis and COPD.
She is currently a research fellow at La Trobe University (postdoctoral position) under Prof Anne Holland. She is the clinical trial manager of the PFOX trial. The PFOX trial will investigate the effects of ambulatory oxygen therapy during exercise to patients with fibrotic interstitial lung disease across 4 Australian centres and 2 Swedish centres.